163 related articles for article (PubMed ID: 11332158)
1. Subcutaneous administration of amifostine: a promising therapeutic option in patients with oxaliplatin-related peripheral sensitive neuropathy.
Penz M; Kornek GV; Raderer M; Ulrich-Pur H; Fiebiger W; Scheithauer W
Ann Oncol; 2001 Mar; 12(3):421-2. PubMed ID: 11332158
[No Abstract] [Full Text] [Related]
2. [Promising effects of pregabalin in the treatment of oxaliplatin-induced sensory neuropathy in patients with colorectal carcinoma].
Nagahara H; Noda E; Maeda K; Inoue T; Hirakawa T; Hasegawa T; Shibutani M; Hirakawa K
Gan To Kagaku Ryoho; 2013 Sep; 40(9):1181-3. PubMed ID: 24047775
[TBL] [Abstract][Full Text] [Related]
3. Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer.
Lersch C; Schmelz R; Eckel F; Erdmann J; Mayr M; Schulte-Frohlinde E; Quasthoff S; Grosskreutz J; Adelsberger H
Clin Colorectal Cancer; 2002 May; 2(1):54-8. PubMed ID: 12453338
[TBL] [Abstract][Full Text] [Related]
4. Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: an open-label pilot study.
Yang YH; Lin JK; Chen WS; Lin TC; Yang SH; Jiang JK; Chang SC; Lan YT; Lin CC; Yen CC; Tzeng CH; Wang WS; Chiang HL; Teng CJ; Teng HW
Support Care Cancer; 2012 Jul; 20(7):1491-7. PubMed ID: 21814779
[TBL] [Abstract][Full Text] [Related]
5. The pain with platinum: oxaliplatin and neuropathy.
Kiernan MC
Eur J Cancer; 2007 Dec; 43(18):2631-3. PubMed ID: 17977714
[No Abstract] [Full Text] [Related]
6. An overview of chemotherapy-induced peripheral sensory neuropathy, focusing on oxaliplatin.
Gent P; Massey K
Int J Palliat Nurs; 2001 Jul; 7(7):354-9. PubMed ID: 11951404
[TBL] [Abstract][Full Text] [Related]
7. Xaliproden lessens oxaliplatin-mediated neuropathy.
Susman E
Lancet Oncol; 2006 Apr; 7(4):288. PubMed ID: 16598880
[No Abstract] [Full Text] [Related]
8. Treatment of oxaliplatin-induced peripheral neuropathy by intravenous mangafodipir.
Coriat R; Alexandre J; Nicco C; Quinquis L; Benoit E; Chéreau C; Lemaréchal H; Mir O; Borderie D; Tréluyer JM; Weill B; Coste J; Goldwasser F; Batteux F
J Clin Invest; 2014 Jan; 124(1):262-72. PubMed ID: 24355920
[TBL] [Abstract][Full Text] [Related]
9. Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: a pilot randomized clinical trial.
Afonseca SO; Cruz FM; Cubero Dde I; Lera AT; Schindler F; Okawara M; Souza LF; Rodrigues NP; Giglio Ad
Sao Paulo Med J; 2013; 131(1):35-8. PubMed ID: 23538593
[TBL] [Abstract][Full Text] [Related]
10. Peripheral neuropathy in patients with colorectal cancer receiving oxaliplatin.
Tofthagen C; McAllister RD; McMillan SC
Clin J Oncol Nurs; 2011 Apr; 15(2):182-8. PubMed ID: 21444285
[TBL] [Abstract][Full Text] [Related]
11. [Evidence from basic studies on mechanisms and treatment drugs for oxaliplatin-induced peripheral neuropathy].
Egashira N; Kawashiri T; Oishi R
Nihon Yakurigaku Zasshi; 2013 Feb; 141(2):66-70. PubMed ID: 23391544
[No Abstract] [Full Text] [Related]
12. A descriptive study of persistent oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer.
Vatandoust S; Joshi R; Pittman KB; Esterman A; Broadbridge V; Adams J; Singhal N; Yeend S; Price TJ
Support Care Cancer; 2014 Feb; 22(2):513-8. PubMed ID: 24122404
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Oxaliplatin-induced Chronic Neuropathy and Influencing Factors in Patients with Colorectal Cancer in Iran.
Shahriari-Ahmadi A; Fahimi A; Payandeh M; Sadeghi M
Asian Pac J Cancer Prev; 2015; 16(17):7603-6. PubMed ID: 26625769
[TBL] [Abstract][Full Text] [Related]
14. Oxaliplatin-safety profile: neurotoxicity.
Grothey A
Semin Oncol; 2003 Aug; 30(4 Suppl 15):5-13. PubMed ID: 14523789
[TBL] [Abstract][Full Text] [Related]
15. Peripheral neuropathy induced by oxaliplatin-based chemotherapy.
J Support Oncol; 2006 Feb; 4(2):82-3. PubMed ID: 16499128
[No Abstract] [Full Text] [Related]
16. Calcium and magnesium for oxaliplatin-induced neuropathy.
Stansfield L
Am J Health Syst Pharm; 2014 Jun; 71(12):987-8. PubMed ID: 24865753
[No Abstract] [Full Text] [Related]
17. [Prevention of oxaliplatin-induced neuropathy by carbamazepine. A pilot study].
Eckel F; Schmelz R; Adelsberger H; Erdmann J; Quasthoff S; Lersch C
Dtsch Med Wochenschr; 2002 Jan; 127(3):78-82. PubMed ID: 11797144
[TBL] [Abstract][Full Text] [Related]
18. Oxaliplatin-induced neuropathy: a tale of two electrolytes.
Babiker HM; Green MR; Nelson MA; Elquza E
Support Care Cancer; 2015 Jun; 23(6):1483-5. PubMed ID: 25801447
[No Abstract] [Full Text] [Related]
19. [Basic evidence for efficacy of Goshajinkigan on oxaliplatin-induced neuropathy].
Ushio S; Kawashiri T; Egashira N
Nihon Yakurigaku Zasshi; 2014 Mar; 143(3):126-30. PubMed ID: 24614635
[No Abstract] [Full Text] [Related]
20. L-Carnosine protects against Oxaliplatin-induced peripheral neuropathy in colorectal cancer patients: A perspective on targeting Nrf-2 and NF-κB pathways.
Yehia R; Saleh S; El Abhar H; Saad AS; Schaalan M
Toxicol Appl Pharmacol; 2019 Feb; 365():41-50. PubMed ID: 30592963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]